Navigation Links
Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
Date:7/15/2013

LAVAL, Quebec, July 15, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Wednesday, August 7, 2013 at 8:00 a.m. ET (5:00 a.m. PT) to discuss results for the 2013 second quarter.

The dial-in number to participate on this call is (877) 876-8393, confirmation code 17202469.  International callers should dial (973) 200-3961, confirmation code 17202469. A replay will be available approximately two hours following the conclusion of the conference call to Wednesday, August 14, 2013, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 17202469.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant can be found at www.valeant.com.

(Logo:  http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
2. Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option
3. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
4. Valeant Pharmaceuticals Prices Public Offering Of Common Shares
5. Valeant Pharmaceuticals Announces Public Offering Of Common Shares
6. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
7. Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole
8. Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
9. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
10. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
11. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ... reported financial results for the second quarter and three and ... are expressed in Canadian dollars and in accordance with International ... ESSA recorded a net loss of $5.9 million ... 31, 2015 (Q2-2015), compared to a net loss of $0.4 ...
(Date:5/28/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... H. Mackaness is scheduled to present at the LD ... PT in Los Angeles . ... on the Event Calendar of the Investors section of IRIDEX,s ... will be available shortly after the conclusion of the presentation ...
(Date:5/28/2015)... 2015 Research and ... of the  "North America Ultrasound Devices Market ... 2019)"  report to their offering.  ... a type of imaging. It uses high-frequency ... and structures inside the body. Health care ...
Breaking Medicine Technology:Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2
... Prolong Pharmaceuticals today announced that industry veteran Glenn Kazo has ... in various capacities with Prolong since 2007. He succeeds Prolong ... "I have known Glenn for more than thirty years," ... Mr. Kazo. "I feel he is one of the greatest ...
... 28 Tigris Pharmaceuticals, Inc., a ... it has completed a private placement of Series ... of approximately $6.5 million.  The financing, which was ... investors Wexford Spectrum Investors, LLC, and Sonostar Capital ...
Cached Medicine Technology:Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President 2Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement 2Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement 3
(Date:5/29/2015)... For the third year, Nike Ultimate Camps will ... ultimate community an opportunity to experience ultimate training techniques in ... of the USAU Nike Ultimate Camp is to provide a ... character, and make lifelong friends. , The USAU Nike Ultimate ... skill and ability levels, ages 10-18. Camp will run from ...
(Date:5/29/2015)... 29, 2015 External Counterpulsation, also known as ... treatment for patients. The Heart Fit Clinic is the first ... a raving review from patients who are now completing treatment. ... underwent 35 treatments of ECP treatment and received great results. ... Not only does the clinic perform this non-surgical treatment for ...
(Date:5/29/2015)... May 29, 2015 An organizational consultant ... he is losing his memory and may be suffering ... in both his professional life and in his uncertain ... with a hob-knobbing career working with corporate and government ... But as multiple family members around him are being ...
(Date:5/29/2015)... Testosterone Centers of Texas (TCT), one of the ... new center in the Mid-Cities area to serve Hurst, Colleyville, ... Located on the south side of Hwy 26, one block ... center will open in May and will offer comprehensive testosterone ... , Like TCT’s other testosterone clinics, this clinic will also ...
(Date:5/29/2015)... 2015 The 3D Certificate program is ... the business, finance, and engineering aspects of evaluating 3D ... technology, an expansion in their existing 3D investment, or ... of 3D technology in manufacturing in various fields, will ... will include courses that cover the following topics: state ...
Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 2Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 3
... published today in a special supplement to the Journal of ... for patients who speak little, if any, English and the ... settings. The studies overall report that measurable disparities in quality ... the same language. , Hospitalized Patients ...
... be most affected, study finds , , THURSDAY, Nov. 1 ... can signal raised cardiovascular risks for an individual,s brothers ... for siblings is particularly strong among brothers, the Johns ... has a heart attack or chest pain from blocked ...
... Friday An unforgettable evening of good ... The 12th Annual Tallahassee,Wine and Food Festival culminates tomorrow ... from around the world, including,unique varietals from Argentina and South ... three fun-filled sessions about wine:, * Basics of Wine ...
... Solution, PHILADELPHIA, Nov. 1 Portico Systems, ... nine-month period of rapid,growth, with revenue climbing 67% ... top 30 health plans -- are,accelerating roll-outs of ... dramatically increases bottom-line performance by,optimizing provider network operations. ...
... Fibromyalgia is the most common,widespread chronic pain condition ... Americans. But, findings from two new surveys commissioned ... still much to be,learned about this debilitating condition. ... nearly half (45%) of respondents,have never heard of ...
... Nov. 1 PetScreen, http://www.pet-screen.com, ... other diseases,attacking pets, has made a generous ... nonprofit,s global effort to cure canine cancer. ... canine cancer research,studies. The MAF Canine Cancer ...
Cached Medicine News:Health News:JGIM: studies show importance of language services on disparities, quality of care 2Health News:JGIM: studies show importance of language services on disparities, quality of care 3Health News:JGIM: studies show importance of language services on disparities, quality of care 4Health News:JGIM: studies show importance of language services on disparities, quality of care 5Health News:Siblings Often Share Heart Risks 2Health News:Siblings Often Share Heart Risks 3Health News:Take a Culinary Trip Around the World for a Good Cause: March of Dimes 2Health News:Portico(TM) Systems Charts Another Period of Rapid Growth 2Health News:Portico(TM) Systems Charts Another Period of Rapid Growth 3Health News:Medialink Features: The Painful Truth About Fibromyalgia 2Health News:PetScreen Supports Morris Animal Foundation Canine Cancer Campaign; Co-Sponsors Two Canine Cancer Studies 2
... a long-pulsed Nd:YAG laser system with a wavelength ... treat deep-lying, superficial as well as red and ... epilation in patients with darker skin types (1 ... as for general improvement of skin texture. The ...
... brachytherapy source consists of a welded titanium ... onto four resin beads. The capsule ... which serve as x-ray markers to identify ... sources are supplied non-sterile when shipped and ...
... SINON is a Q-switched ruby ... of 694 nm. High Performance ... - This combination of high ... in Q-switched mode effectively destroys ...
A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for,Disease Progression and Recurrence....
Medicine Products: